The Impact of Bispectral Index Monitoring on Sedation Administration in

Status Completed

Clinical Trial Summary

This prospective randomised controlled trial was designed to assess the effectiveness of the Bispectral Index Sedation (BIS) monitor in supporting clinical, sedation management decisions in mechanically ventilated ICU patients.

The primary hypothesis for the study is that patients with Bispectral Index Sedation (BIS) monitoring will receive less sedation then those receiving standard sedation management.

The secondary hypotheses are:

1. Patients with BIS have fewer ventilation days than those receiving standard sedation management.

2. Level of sedation administered will differ according to the critical care experience and qualification of the nurse.

Clinical Trial Description

Patients in intensive care units (ICUs) frequently require sedatives and analgesics as part of therapy. Assessing the appropriate dose of sedative and analgesic drugs can be difficult due to the severity of the patient's illness, inability of the patient to communicate, multiple procedures and transports for investigations and the subjectivity of clinical sedation assessment tools. Poorly assessed and managed levels of sedation can result in over sedation, extended ventilation time and a potentially extended ICU stay.

The BIS monitor is derived from the electroencephalogram and provides a numeric value that represents a measure of cerebral activity. Such an objective measure of the patient's level of sedation may provide a useful tool that will enable nurses to titrate sedation more accurately in an attempt to provide the optimal level of sedation for all ICU patients.

The study will be conducted in the Intensive Care Unit at the Alfred Hospital. This study is designed as a prospective randomised control trial with parallel design. This means that participants' will be randomly allocated into either one of two groups - an intervention or control group. Participant's randomised to the intervention group will receive BIS monitoring. The control group will receive standard ICU sedation assessment and management.

To determine if BIS monitoring is useful in ICU, information will be collected by auditing patient charts and determining the average amounts of sedation medication for each nursing shift. In addition, the years of critical care experience and critical care qualification will be recorded for each nurse managing patients recruited to the study. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01997931
Study type	Interventional
Source	Bayside Health
Contact
Status	Completed
Phase	N/A
Start date	September 2004
Completion date	July 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00487097` - The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients	N/A
Recruiting	`NCT04926220` - Dynamic Estimation of Cardiac Output in the Operating Room
Not yet recruiting	`NCT03617796` - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Withdrawn	`NCT04554264` - Complicated Grief in ICU in the Aftermath of COVID-19	N/A
Recruiting	`NCT02587273` - The Pharmacokinetics of Fentanyl in Intensive Care Patients	Phase 4
Withdrawn	`NCT01749488` - The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care	N/A
Recruiting	`NCT06110390` - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients	N/A
Completed	`NCT04186611` - Early Occupational Therapy in Intensive Care: Feasibility of Implementation	N/A
Completed	`NCT03299894` - Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department	N/A
Recruiting	`NCT03777150` - Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients?	N/A
Completed	`NCT02583321` - Detection of Chlorhexidine in Tracheal Secretions After Routine Oral Care With Chlorhexidine Gluconate	N/A
Completed	`NCT00787098` - Investigating Modes of Progressive Mobility	Phase 2
Recruiting	`NCT04114747` - Renal Physiology During Continuous Renal Replacement Therapy	N/A
Completed	`NCT02476591` - Charge Transparency in Critical Care Practice and Its Effects on Overall Cost of Care	N/A
Completed	`NCT05795777` - Examination of the Pressure Ulcers in Intensive Care Patients.
Terminated	`NCT02587130` - Ketamine and Refractory Painful Care in a Palliative Unit	Phase 4
Completed	`NCT02463123` - Energy Expenditure Estimation in Cardiac Surgery	N/A
Completed	`NCT01607723` - "NAVA-PAV" Study: a Cross-over Comparative Study of 2 Advanced Modes	Phase 3
Completed	`NCT01346813` - Epidemiology of Painful Procedures in Neonates	N/A
Completed	`NCT00410852` - Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Impact of Bispectral Index Monitoring on Sedation Administration in Mechanically Ventilated Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms